POTS is mis-categorized as Dysautonomia which affects in how it is treated

Postural Orthostatic Tachycardia Syndrome: misclassified as Dysautonomia

Pradeep Chopra, MD, MHCM

Introduction

Postural Orthostatic Tachycardia Syndrome (POTS) is a condition characterized by a heart rate increase upon standing (≥30 bpm in adults, or over 120 bpm) within the first 10 minutes of standing. In children and adolescents a heart rate change of ≥40 bpm without significant change in blood pressure is accepted as the standard. Common symptoms include dizziness, palpitations, fatigue, “brain fog,” and even fainting upon upright posture. It is often described as a form of dysautonomia – a disorder of the autonomic nervous system (ANS). However, emerging evidence suggests that in many cases POTS may not reflect a malfunctioning autonomic system at all, but rather a normal physiological compensatory response to other underlying problems. This review examines the mechanisms behind POTS, arguing that the syndrome frequently represents an appropriate cardiovascular reflex to abnormal circumstances (such as blood pooling or structural compression), rather than an inherently “broken” autonomic nervous system. Both adult and pediatric POTS populations are considered, as POTS affects all ages (with at least one-third of cases developing before age 18).

‍

What Does “Dysautonomia” Imply in POTS?

‍

Labeling POTS as a dysautonomia implies autonomic nervous system dysfunction – that the ANS is failing to respond normally. True dysautonomia typically means the autonomic nervous system either fails to respond when it should, responds inappropriately, or cannot maintain basic physiological stability. In classic autonomic nervous system failure, patients cannot adequately regulate blood pressure or heart rate upon standing, often leading to immediate hypotension and syncope (fainting) due to an inability to compensate. Indeed, conditions like pure autonomic neuropathy or neurogenic orthostatic hypotension exemplify dysautonomia: the heart rate does not rise enough and blood pressure collapses on standing because of ANS  failure.

‍

By contrast, most POTS patients do not experience a dramatic blood pressure drop on standing. Instead, they mount a tachycardic response and typically maintain blood pressure, avoiding syncope. This preserved blood pressure with tachycardia is evidence of an intact and responsive sympathetic nervous system, not a failing one. The body is sensing a hemodynamic challenge and appropriately activating the sympathetic “fight or flight” reflex to stabilize circulation. In other words, the hallmark tachycardia in POTS is a compensation, not a primary malfunction. As one report succinctly put it, “This is textbook physiology. If the autonomic nervous system were dysfunctional, patients would experience immediate hypotension and syncope. Instead, they experience tachycardia with preserved blood pressure, which is evidence of an intact and responsive sympathetic system.”. Thus, the traditional label of dysautonomia may be misleading for many POTS patients, as it obscures the fact that the autonomic reflexes are often working exactly as designed – the problem lies upstream (in the circulatory mechanics or other triggers) rather than in the nervous system itself.

‍

POTS as a Normal Orthostatic Reflex – The Case of Blood Pooling

‍

One of the most common contributors to POTS symptoms is excessive venous blood pooling upon standing. Normally, when a healthy person stands up, gravity causes 500–1000 mL of blood to shift to the abdomen and legs. Baroreceptors sense the reduced venous return to the heart and trigger sympathetic outflow, causing a slight rise in heart rate (10–20 bpm), stronger heart contraction, and vasoconstriction to maintain cardiac output and blood pressure. In patients with POTS, this normal orthostatic reflex overshoots – heart rate rises by 30+ bpm – but crucially, this happens because the body needs to compensate more than usual to maintain circulation. Often, the underlying issue is that too much blood is pooling in the splanchnic veins in the abdomen and pelvis, thighs and buttocks due to vascular or connective tissue abnormalities.

Patients with Ehlers-Danlos syndrome (EDS) and other connective tissue disorders exemplify this mechanism. In hypermobile EDS, connective tissue weakness leads to overly compliant veins upon standing:

1. Venous pooling occurs excessively in the thighs, buttocks, pelvis, and abdomen because veins do not adequately constrict.
2. Reduced venous return to the heart causes a drop in cardiac preload
3. The body perceives threatened cardiac output to the brain (incipient low blood flow) and activates the sympathetic nervous system appropriately.
4. The result is a rapid heart rate and peripheral vasoconstriction – an effort to prop up blood pressure and maintain cerebral perfusion.

Far from being “inappropriate,” this tachycardia is exactly what a well-functioning autonomic system should do to prevent fainting. The sympathetic nervous system correctly detects reduced circulating volume and responds appropriately: heart rate increases, cardiac output rises, blood pressure is maintained, and loss of consciousness is prevented. This is not a malfunction of the ABS.  In patients with POTS (especially those with EDS), the heart is racing to rescue the brain from the effects of gravity and vascular elasticity, just as it might during vigorous exercise or dehydration. We do not call the elevated heart rate during exercise a disease; similarly, the elevated heart rate in these POTS cases is a compensatory mechanism, not a pathological overreaction. The conditions triggering the response are abnormal, but the response itself is normal.

‍

Importantly, studies indicate a strong overlap between hypermobility syndromes and POTS. Up to 40% of patients with EDS have some form of orthostatic intolerance such as POTS, and conversely a notable subset of POTS patients (around 18–30% in different studies) meet criteria for hypermobile EDS or related connective tissue disorders. This connection supports a mechanical hemodynamic origin for many POTS cases: weak connective tissue leads to blood pooling, which in turn forces the autonomic system to respond vigorously. Patients often exhibit physical signs of pooling, such as a reddish-purple discoloration of the legs on standing (dependent acrocyanosis) due to blood stagnating in the extremities. Therapies that improve venous return – e.g. compression shorts, fluid and salt loading, physical counter-maneuvers – frequently alleviate POTS symptoms, further evidence that the core issue is circulatory volume distribution rather than a primary ANS defect. In sum, for a large subset of patients, POTS is a state of orthostatic stress caused by “bottom-up” vascular factors, with the tachycardia representing a successful autonomic compensation to uphold cardiac pre-load. They do not faint precisely because their autonomic reflexes are intact and compensating; mislabeling such cases as dysautonomia can misdirect treatment, focusing on blunting heart rate rather than fixing the venous pooling that provokes the tachycardia.

‍

Cervicomedullary Syndrome: Structural Compression Causing POTS

‍

Another scenario where POTS appears as a secondary phenomenon is in Cervicomedullary syndrome – conditions like Chiari malformation or Craniocervical instability (CCI) that cause structural compression of the brainstem and upper spinal cord. The lower brainstem (medulla) houses key autonomic centers (the cardiovascular and vasomotor centers), and compression in this area can disrupt normal autonomic regulation. Patients with hypermobile connective tissue (e.g. EDS) are predisposed not only to POTS but also to CCI and Chiari Malformation due to weak ligamentous support at the craniocervical junction. In fact, the triad of hypermobile EDS, POTS, and Chiari I malformation is recognized in clinical practice.

‍

In such patients, the mechanism of POTS may relate to brainstem distortion or impaired cerebrospinal fluid flow rather than peripheral blood pooling alone. For example, cerebellar tonsillar herniation in Chiari can crowd the brainstem and upper spinal cord, potentially disturbing baroreceptor signaling or vagal pathways. One case series reported 10 patients with Chiari I malformation, seven of whom had improvement or resolution of syncopal episodes and orthostatic intolerance after surgical decompression of the hindbrain. Another case report documented a patient whose POTS symptoms completely resolved after Chiari malformation surgery. Similarly, anecdotal reports exist of POTS improvements after CCI fusion surgery in patients with instability. Basilar Invagination is an abnormality at the craniovertebral junction, resulting in the Odontoid process prolapsing into the already limited space at the foramen magnum. This may be seen in Chiari Malformation, Klippel-Feil syndrome or Syringomyelia. These observations strongly suggest that structural compression at the cervicomedullary junction can induce POTS like symptoms and relieving that compression can reverse the orthostatic tachycardia. In other words, POTS in these cases is secondary to a mechanical neural disruption. Notably, standard MRI measurements of tonsillar descent may underestimate functional brainstem compression; patients with “normal” tonsil position can still have brainstem crowding or CCI that affects autonomic control. As one review noted, some POTS patients may have craniocervical instability causing intermittent medullary compression where autonomic networks reside, even if an overt Chiari malformation isn’t diagnosed.

‍

Cervical medullary syndrome from CCI can produce a constellation of symptoms: headaches, dizziness, tremors, syncope, and orthostatic tachycardia. In a 5-year follow-up study of hypermobile patients undergoing CCI surgery, most had POTS or other autonomic manifestations pre-operatively. After fusion/stabilization, POTS symptoms often improved along with other neurological symptoms. This underscores that when POTS stems from a structural cause, it is again not a case of an intrinsically overactive ANS – instead, the autonomic system was being disrupted or over-taxed by mechanical factors, and fixing those factors allows autonomic reflexes to normalize. It’s comparable to releasing a pinched nerve: once the brainstem is decompressed, the autonomic outflow can operate properly without the previously necessary exaggerated heart rate.

‍

A related consideration is Spontaneous Intracranial Hypotension (SIH), a condition where there is low cerebrospinal fluid pressure often due to Cerebrospinal Fluid CSF leaks. SIH can cause orthostatic headaches and has significant symptom overlap with POTS. Remarkably, one case series found that all SIH patients met clinical criteria for POTS. In one patient, treating the CSF leak with a blood patch cured both the intracranial hypotension and the POTS symptoms. This again suggests that POTS can be a downstream effect of another disorder (in this case, low CSF volume) – the tachycardia was a compensatory response or side-effect of the primary problem, and it resolved when the primary problem was fixed.

‍

In summary, cervicomedullary structural abnormalities and Basilar Invagination can precipitate POTS by interfering with central autonomic pathways or hemodynamics, but when addressed (through surgical decompression, stabilization, or repair of CSF leaks), the “dysautonomia” often improves. These cases reinforce the idea that POTS is heterogeneous and often secondary to other pathologies – mechanical or structural issues in this scenario – rather than a stand-alone autonomic defect. It’s further evidence that we should seek and treat underlying causes (like Chiari, CCI, SIH, Basilar Invagination) in POTS patients, instead of reflexively attributing everything to an idiopathic autonomic disorder.

‍

Autoimmune-Mediated POTS: Dysautonomia or Immune Trigger?

‍

A significant subset of POTS patients show evidence of autoimmune activation, suggesting yet another causal pathway. Many patients report their POTS symptoms began after a viral illness, vaccination, pregnancy, or other immune-modulating event. Additionally, POTS predominantly affects young women (female ~80–90% of cases), paralleling the female predominance seen in many autoimmune diseases. These clues have led researchers to investigate autoimmunity in POTS. The findings are striking: approximately 20% of POTS patients have a diagnosable autoimmune disorder(such as lupus, Sjögren’s syndrome, or Hashimoto’s thyroiditis) as a co-morbidity. Even among those without a defined autoimmune disease, the majority test positive for some nonspecific autoimmune markers – for example, one retrospective study found 25% of POTS patients had anti-nuclear antibodies (ANA) and others had various circulating autoantibodies, despite not meeting criteria for a specific autoimmune condition.

‍

More directly, researchers have identified autoantibodies against autonomic receptors in many POTS patients. These include antibodies targeting the ganglionic acetylcholine receptor (gAChR) in autonomic ganglia, beta-1 and beta-2 adrenergic receptors, alpha-1 adrenergic receptors, and muscarinic acetylcholine receptors M1/M2/M4. For example, one study detected anti-gAChR antibodies in about 29% of POTS patients tested. Other studies showed nearly all POTS patients (in small samples) had antibodies that could bind to and activate adrenergic receptors, potentially causing receptor dysfunction. The presence of these antibodies hints at an autoimmune attack on the autonomic nervous system at a receptor or ganglion level. Unlike the mechanical cases above, here the autonomic nerves themselves (or their receptors) may be directly affected by the immune system – this does edge closer to a true “dysautonomia” in the sense of an immune-mediated autonomic dysfunction.

‍

However, even in these autoimmune dysfunction scenarios, the resulting orthostatic tachycardia can be viewed as a compensatory outcome. If autoantibodies or small-fiber neuropathy (which is found in ~50% of POTS patients on specialized testing) impair the normal vasoconstriction in the peripheral blood vessels, the body will respond by increasing heart rate to maintain blood flow. In essence, the immune system may create a partial autonomic impairment (less effective vasomotor tone), but the intact portions of the system compensate with more vigorous cardiac output – yielding POTS. In support of the immune link, about 78% of POTS patients have a history of acute stressor or infection preceding onset, and many have a personal or family history of other autoimmune diseases. Patients with POTS also have higher than expected rates of conditions like celiac disease, autoimmune thyroid disease, and Sjögren’s. Moreover, some patients with “autoimmune POTS” respond to immunotherapy: case reports describe improvement in POTS symptoms with treatments like IV immunoglobulin, plasmapheresis, or immunosuppressants in select individuals. These cases suggest that tamping down immune activity can ameliorate the autonomic imbalance, reinforcing the idea that immune dysregulation was a driver of the POTS in those patients.

‍

It’s important to clarify that autoimmunity likely accounts for only a subset of POTS cases. The field has not identified a single “POTS antibody” present in all patients; instead, multiple different antibodies have been noted in different people, and their pathogenic role is still under investigation. Thus, while POTS is not purely psychogenic or “all in the head” it is also not a uniform disorder – some cases are mechanical, some neuropathic, some autoimmune, and many a mixture of factors. When actual autoimmune dysfunction is present, one could argue there is an element of true dysautonomia (since the autonomic nerves are under immune attack). But even here, the final common pathway is that the tachycardia is a compensatory response to a circulatory challenge – for instance, if autoantibodies cause peripheral vasodilation or denervation, the heart must beat faster to keep blood pressure up. This aligns with the overarching theme: POTS symptoms arise from the body struggling to maintain homeostasis against some insult (be it pooling, compression, or immune injury), rather than from an inexplicable hyperactivation of the ANS. In many patients with POTS,  sympathetic activation is a necessary effort to counteract low effective blood volume or vessel tone, and their symptoms (like tachycardia, fatigue, tremor) are signs of a physiologic system pushed to its limits.

‍

POTS in Pediatric vs. Adult Patients

‍

POTS is often thought of as a condition of adolescents and young adults, and indeed onset frequently occurs in the teenage years. At least one-third of POTS patients develop the syndrome before age 18, and adolescence (ages ~12–19) is a peak period for POTS to emerge. The syndrome’s core feature – orthostatic tachycardia with symptoms – is consistent between pediatric and adult populations. Both experience similar complaints of lightheadedness, rapid pulse, exercise intolerance, etc., and in both groups POTS overwhelmingly affects females more than males. Diagnostic criteria differ slightly: in teens, a ≥40 bpm heart rate increment is used (versus 30 bpm in adults) because children naturally have higher resting heart rates and orthostatic responses. Otherwise, the definition (symptoms of orthostatic intolerance for ≥6 months, absence of significant blood pressure drop) is the same.

‍

Where pediatric POTS can differ is in its triggers and course. Many adolescents with POTS have a post-viral onset (e.g. after mononucleosis) or follow rapid growth spurts. Some pediatric patients have a more benign course, with improvement over time or even resolution in young adulthood – possibly as their blood volume catches up with body size or their autonomic system matures. Nonetheless, pediatric POTS can be quite debilitating, interfering with schooling and social development. Unique challenges in youth include managing school attendance (homebound instruction may be needed during flares), addressing parental concerns, and distinguishing POTS from anxiety or panic (which it is often mistakenly attributed to). The pathophysiology in kids appears comparable to adults: deconditioning, hypovolemia, and connective conditions are common factors in teens with POTS, similar to older patients. One notable point is that adolescence is a time of dynamic autonomic recalibration, and POTS may represent a transient dysregulation in some cases. For instance, one review notes that many adult POTS patients recall having symptoms in their teen years, implying that adolescence is when the seeds of the syndrome are often sown. Early recognition in pediatric patients is improving, and research specific to youth is growing (though still less abundant than adult POTS research).

‍

From a treatment perspective, the same principles apply to children and adults: increase fluid and salt intake, encourage gradual supine muscle movement, use compression shorts, and consider medications judiciously. The key, however, is to identify any treatable underlying cause. In both populations, one should ask: Is there evidence of a connective tissue disorder? Could this be an after-effect of a viral infection or an autoimmune process? Is there any sign of Chiari malformation or craniocervical instability or cervicomedullary syndrome? By answering these questions, clinicians can move beyond simply labeling a young patient with “dysautonomia” and instead tailor management to their specific situation – whether that means muscle movements and compression for a patient with connective tissue disorder, immunotherapy for an autoimmune case, or neurosurgery referral for a brainstem compression.

‍

Conclusion

‍

POTS is a heterogeneous syndrome and should not be viewed as a one-size-fits-all autonomic disorder. In many patients – especially those with conditions like hypermobile EDS – the autonomic nervous system is functioning appropriately, if not admirably, in the face of an abnormal challenge. Their tachycardia upon standing is an adaptive response to maintain blood flow when blood pools in the extremities. Calling this appropriate reflex “dysautonomia” is misleading; as one expert noted, it’s akin to calling the increased heart rate during exercise a disease. The misclassification of POTS as a primary autonomic dysfunction has consequences: patients may be incorrectly told that their “nervous system is broken,” and treatment may fixate on suppressing heart rate or nervous system activity instead of addressing root causes (e.g. improving venous return, treating autoimmunity). By contrast, reframing POTS in many cases as a compensatory orthostatic tachycardia encourages a search for underlying contributors – be it hypovolemia, peripheral pooling, connective tissue laxity, mast cell activation, autoimmune neuropathy, or structural compression. Indeed, “what appears to be POTS may be an underlying condition that requires specific therapy… POTS is not a single disease, and it should not be explained with a single label.”.

‍

In practical terms, recognizing POTS as often secondary to mechanical or immune issues leads to more effective management. For example, an EDS patient’s tachycardia might improve not with high-dose beta blockers (which can cause fatigue), but with compression stockings, volume expansion, and physical therapy for muscle pumping – because her autonomic reflex is intact, and the real issue is venous pooling. An autoimmune POTS patient might benefit from IVIG or corticosteroids in refractory cases, rather than being dismissed as having anxiety – because we acknowledge an immune basis and treat the inflammation. A patient with POTS and occipital headaches might warrant an MRI to rule out Chiari or a CSF leak patch, rather than simply adding more medications. In essence, POTS should be approached as a syndrome with multiple potential causes – not as a lone diagnosis of “dysautonomia”. The tachycardia is the body’s SOS signal; our job is to find out why the body is under orthostatic stress and address that root cause.

‍

In conclusion, mounting evidence indicates that POTS is frequently a normal physiological response to abnormal conditions, rather than an abnormal response of a normal system. The autonomic nervous system in POTS is often doing its job correctly – it is we who must do a better job in interpreting the signal, classifying patients appropriately, and providing targeted therapies. Adopting this perspective can improve explanations to patients (“your high heart rate is your body’s clever way of keeping you upright, let’s figure out what’s making it work so hard”) and lead to better outcomes. As research continues, particularly into autoimmune pathways and long-term outcomes in pediatric POTS, we move closer to a refined understanding of this condition. But even now, a paradigm shift is warranted: it’s time to stop reflexively calling POTS a dysautonomia in every case, and start recognizing it as, in many instances, a sign of the body’s resilience – a heroic heart compensating for challenges below the neck. By respecting POTS as a compensatory syndrome, we validate patients’ experiences and open the door to treatments that address the true underlying issues, ultimately improving quality of life for both adult and pediatric POTS sufferers.

‍

Sources:

‍

‍

• Henderson FC et al. “Cervical medullary syndrome secondary to craniocervical instability in hereditary connective tissue disorders: 5-year follow-up after fusion.” Neurosurg Rev. 2019.
• Blitshteyn S. “Is postural orthostatic tachycardia syndrome (POTS) a central nervous system disorder?” Auton Neurosci. 2021.
• Nakane S et al. “Autoimmune postural orthostatic tachycardia syndrome.” Ann Clin Transl Neurol. 2018.
• Vernino S, Stiles LE. “Autoimmunity in postural orthostatic tachycardia syndrome: current understanding.” Auton Neurosci. 2018.
• Boris JR. “Postural orthostatic tachycardia syndrome in children and adolescents.” Auton Neurosci. 2018.
• Kanjwal K, Karabin B, Kanjwal Y, Grubb BP. “Postural orthostatic tachycardia syndrome: a comprehensive approach to evaluation and management.” Pogress in Cardiovascular Diseases. 2013. (Discussions on POTS subtypes and pathophysiology)
• Additional references: Dysautonomia International (patient education material); NursingCECentral POTS course (for physiologic details); Frontiers in Neurology 2024 (EDS-POTS overlap data).https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2024.1379646/full#:~:text=There%20is%20an%20increased%20prevalence,lead%20to%20more%20timely%20and

‍